AZNH:BATS-AstraZeneca PLC ADRhedged (USD)

ETF | Others |

Last Closing

USD 44.7631

Change

-0.40 (-0.88)%

Market Cap

N/A

Volume

1.33K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The Series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts ("ADRs") of AstraZeneca PLC (the "Company"). The Series will not invest directly in the Company. ADRs are receipts, issued by an American bank or trust issuer, which evidence ownership of underlying securities issued by a non-U.S. issuer. The fund is non-diversified.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
FBTC Fidelity Wise Origin Bitcoin T..

+1.68 (+2.26%)

USD 16.66B
INDA iShares MSCI India ETF

+0.51 (+1.00%)

USD 8.63B
PAVE Global X U.S. Infrastructure D..

+0.64 (+1.68%)

USD 7.86B
BUFR First Trust Cboe Vest Fund of ..

+0.13 (+0.44%)

USD 6.45B
BOXX Alpha Architect 1-3 Month Box ..

+0.01 (+0.01%)

USD 5.42B
BBUS JPMorgan BetaBuilders U.S. Equ..

+0.71 (+0.70%)

USD 4.20B
ARKB ARK 21Shares Bitcoin ETF

+1.97 (+2.32%)

USD 3.92B
KNG FT Cboe Vest S&P 500® Dividen..

+0.18 (+0.36%)

USD 3.66B
GSUS Goldman Sachs MarketBeta US Eq..

+0.57 (+0.74%)

USD 2.47B
IFRA iShares U.S. Infrastructure ET..

+0.62 (+1.37%)

USD 2.19B

ETFs Containing AZNH

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.44% 91% A- 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.44% 91% A- 89% A-
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike